HCA Healthcare/$HCA
1D1W1MYTD1Y5YMAX
Capital at risk
About HCA Healthcare
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
- Ticker
- $HCA
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 275,000
- Headquarters
- Nashville, United States
- Website
- www.hcahealthcare.com
HCA Healthcare Metrics
BasicAdvanced
$92B
14.24
$29.87
1.13
$3.00
0.73%
Price and volume
Market cap
$92B
Beta
1.13
52-week high
$556.52
52-week low
$353.99
Average daily volume
1.3M
Dividend rate
$3.00
Financial strength
Current ratio
0.993
Quick ratio
0.775
Long term debt to equity
-14.113
Total debt to equity
-16.065
Dividend payout ratio (TTM)
9.97%
Interest coverage (TTM)
5.21%
Profitability
EBITDA (TTM)
15,747
Gross margin (TTM)
42.58%
Net profit margin (TTM)
8.77%
Operating margin (TTM)
15.48%
Effective tax rate (TTM)
20.44%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
12.29%
Return on equity (TTM)
-353.18%
Valuation
Price to earnings (TTM)
14.243
Price to revenue (TTM)
1.232
Price to book
-13.96
Price to tangible book (TTM)
-5.36
Price to free cash flow (TTM)
16.031
Free cash flow yield (TTM)
6.24%
Free cash flow per share (TTM)
26.541
Dividend yield (TTM)
0.71%
Forward dividend yield
0.73%
Growth
Revenue change (TTM)
7.31%
Earnings per share change (TTM)
25.89%
3-year revenue growth (CAGR)
8.01%
10-year revenue growth (CAGR)
6.73%
3-year earnings per share growth (CAGR)
13.66%
10-year earnings per share growth (CAGR)
17.87%
3-year dividend per share growth (CAGR)
8.95%
What the Analysts think about HCA Healthcare
Analyst ratings (Buy, Hold, Sell) for HCA Healthcare stock.
Analyst projections of the future price of HCA Healthcare stock.
Bulls say / Bears say
HCA’s Q2 revenue rose 8.7% year-over-year to $20.23 billion and adjusted EPS increased 11.0% to $7.59, topping consensus on robust volume and pricing trends (Reuters).
Medicaid Supplemental Payment Programs provided approximately $400 million of incremental net benefit in Q2, helping offset exchange coverage losses and supporting operating margins (Reuters).
Despite near-term headwinds, HCA shares trade at 12x forward earnings versus 15x three months ago, implying an attractive valuation with a consensus 22.8% upside to $462.50 price targets (Reuters).
HCA cut its full-year profit forecast on July 14, lowering its 2026 EPS outlook from $29.10–31.50 to $28.70–30.50 per diluted share, weighed by an increase in uninsured patients and rising uncompensated care costs (Reuters).
Shares of HCA Healthcare slid 6.6% in morning trading after the company released preliminary Q2 results and trimmed its full-year guidance, reflecting investor concern over a deteriorating payer mix (Investing.com).
A payer mix shift driven by patients losing coverage on ACA exchanges negatively impacted Q2 income by approximately $400 million, underscoring the headwind from expiring premium tax credits (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 24 Aug 2026.
HCA Healthcare Financial Performance
Revenues and expenses
HCA Healthcare Earnings Performance
Company profitability
Upcoming events
HCA Healthcare News
AllArticlesVideos
Funds containing HCA Healthcare
AllEURUSDGBP
Fund name | Fund size | $HCA weighting |
|---|---|---|
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.07% |
iShares Ageing Population€AGED | €822M | 0.53% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.44% |
iShares MSCI USA SRI€QDVR | €2.9B | 0.44% |
iShares MSCI USA SRI£SUUS | £2.5B | 0.44% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.